References
- Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.
- Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst. 1993;85:457–464.
- Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359:1367–1380.
- Field RW, Withers BL. Occupational and environmental causes of lung cancer. Clin Chest Med. 2012;33:681–703.
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
- Wao H, Mhaskar R, Kumar A. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis. Sys Rev. 2013;2:10. http://www.systematicreviewsjournal.com/content/2/1/10.
- Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–236.
- Wei Q, Xu W, Han M, et al. Doxorubicin-mediated radiosensitivity in multicellular spheroids from a lung cancer cell line is enhanced by composite micelle encapsulation. Int J Nanomedicine. 2012;7:2661–2671.
- Pawar R, Jadhav W, Bhusare S, et al. Polysaccharides as carriers of bioactive agents for medical applications. In: Reis RL, Neves NM, Mano JF, Gomes ME, Marques AP, Azevedo HS, editors. Natural based polymers for biomedical applications, 1st ed. Boca Raton, FL: CRC Press LLC; 2008. pp. 3–53.
- Mizrahy S, Peer D. Polysaccharides as building blocks for nanotherapeutics. Chem Soc Rev. 2012;41:2623–2640.
- Basu A, Kunduru KR, Abtew E, et al. Polysaccharide-based conjugates for biomedical applications. Bioconjugate Chem. 2015;26:1396–1412.
- Saravanakumar G, Park JH, Kim K, et al. Polysaccharide-based drug conjugates for tumor targeting, In: Kratz F, Senter P, Steinhagen H, editors. Drug delivery in oncology: from basic research to cancer therapy. KGaA, Boschstr. Weinheim, Germany: Wiley-VCH Verlag & Co.; 2011. pp. 701–746.
- Kim S, Kim J-H, Jeon O, et al. Engineered polymers for advanced drug delivery. Eur J Pharm Biopharm. 2009;71:420–430.
- Galbis JA, García-Martín M, de G, de Paz MV. Synthetic polymers from sugar-based monomers. Chem Rev. 2016;116:1600–1636.
- Liu X, Siegrist S, Amacker M, et al. Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidate. ACS Chem Biol. 2006;1:161–164.
- Fernández N, Alonso S, Valera I, et al. Mannose-containing molecular patterns are strong inducers of cyclooxygenase-2 expression and prostaglandin E2 production in human macrophages. J Immunol. 2005;174:8154–8162.
- Nguyen DG, Hildreth J. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur J Immunol. 2003;33:483–493.
- Schultze JL, Schmieder A, Goerdt S. Macrophage activation in human diseases. Semin Immunol. 2015;27:249–256.
- Francis AP, Gurudevan S, Jayakrishnan A. Synthetic polymannose as a drug carrier: synthesis, toxicity and anti-fungal activity of polymannose-amphotericin B conjugates. J Biomater Sci Polym Ed. 2018;29:1529–1548.
- Nishi KK, Antony M, Mohanan PV, et al. Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against leishmania and fungi. Pharm Res. 2007;24:971–980.
- Ravichandran V, Kesavan V, Cojean S, et al. Polysorbate surfactants as drug carriers: Tween 20-amphotericin B conjugates as anti-fungal and anti-leishmanial agents. Curr Drug Deliv. 2018;15:1028–1037.
- Bulmus V, Woodward M, Lin L, et al. A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs. J Control Release. 2003;93:105–120.
- Francis AP, Murthy PB, Devasena T. Bis-demethoxy curcumin analog nanoparticles: synthesis, characterization, and anticancer activity in vitro. J Nanosci Nanotech. 2014;14:4865–4873.
- Prasad SR, Kumar TSS, Jayakrishnan A. Ceramic core with polymer corona hybrid nanocarrier for the treatment of osteosarcoma with co-delivery of protein and anti-cancer drug. Nanotechnology. 2018;29:015101.
- Zhao H, Heindel ND. Determination of degree of substitution of formyl groups in polyaldehyde dextran by the hydroxylamine hydrochloride method. Pharm Res. 1991;8:400–402.
- Gomez CG, Rinaudo M, Villar MA. Oxidation of sodium alginate and characterization of the oxidized derivatives. Carbohydr. Polym. 2007;67:296–304.
- Balakrishnan B, Lesieur S, Labarre D, et al. Periodate oxidation of sodium alginate in water and in ethanol-water mixture: a comparative study. Carbohydr Res. 2005;340:1425–1429.
- Bouhadir KH, Hausman DS, Mooney DJ. Synthesis of cross-linked poly(aldehyde guluronate) hydrogels. Polymer. 1999;40:3575–3584.
- Agarwal A, Gupta U, Asthana A, et al. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials. 2009;30:3588–3596.
- Kumari S, Ram B, Kumar D. Nanoparticles of oxidized-cellulose synthesized by green method. Mater Sci Energy Technol. 2018;1:22–28.
- Li J, Zhang L, Lin Y, et al. A pH-sensitive prodrug micelle self-assembled from multi-doxorubicin-tailed polyethylene glycol for cancer therapy. RSC Adv. 2016;6:9160–9163.
- Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science. 2004;303:1818–1822.
- Zhao Z, Huang D, Yin Z, et al. Magnetite nanoparticles as smart carriers to manipulate the cytotoxicity of anticancer drugs: magnetic control and pH-responsive release. J Mater Chem. 2012;22:15717. http://xlink.rsc.org/?DOI=c2jm31692g.
- Ding C, Tong L, Feng J, et al. Recent advances in stimuli-responsive release function drug delivery systems for tumor treatment. Molecules. 2016;21:1715. http://www.mdpi.com/1420-3049/21/12/1715.
- Gurudevan S, Francis AP, Jayakrishnan A. Amphotericin B-albumin conjugates: synthesis, toxicity and anti-fungal activity. Eur J Pharm Sci. 2018;115:167–174.
- Henderson C, Metz E, Balcerzak S, et al. Adriamycin and daunomycin generate reactive oxygen compounds in erythrocytes. Blood. 1978;52:878–885.
- Shinohara K, Tanaka KR. The effects of adriamycin (doxorubicin HCl) on human red blood cells. Hemoglobin. 1980;4:735–745.
- Chen C, Cheng YC, Yu CH, et al. In vitro cytotoxicity, hemolysis assay, and biodegradation behavior of biodegradable poly(3-hydroxybutyrate)-poly(ethylene glycol)-poly(3-hydroxybutyrate) nanoparticles as potential drug carriers. J Biomed Mater Res. 2008;87A:290–298.
- Zhao C, Shao L, Lu J, et al. Tumor acidity-induced sheddable polyethylenimine-poly(trimethylene carbonate)/DNA/polyethylene glycol-2,3-dimethyl maleic anhydride ternary complex for efficient and safe gene delivery. ACS Appl Mater Interfaces. 2016;8:6400–6410.
- Qi H, Xin L, Xu X, et al. Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis. J Transl Med. 2014;12:22.
- Sahu PK, Mishra DK, Jain N, et al. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel. Drug Dev Ind Pharm. 2015;41:640–649.
- Jain A, Agarwal A, Majumder S, et al. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. J Control Release. 2010;148:359–367.
- Larson N, Ghandehari H. Polymeric conjugates for drug delivery. Chem Mater. 2012;24:840–853.